Agilent Technologies, Inc. (NYSE:A) Shares Sold by Jupiter Asset Management Ltd.

Jupiter Asset Management Ltd. cut its position in Agilent Technologies, Inc. (NYSE:A) by 10.8% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 407,645 shares of the medical research company’s stock after selling 49,450 shares during the quarter. Jupiter Asset Management Ltd.’s holdings in Agilent Technologies were worth $54,763,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors have also modified their holdings of A. Vestal Point Capital LP acquired a new position in Agilent Technologies during the 3rd quarter worth $14,848,000. Empowered Funds LLC grew its stake in Agilent Technologies by 29.8% during the 3rd quarter. Empowered Funds LLC now owns 30,978 shares of the medical research company’s stock worth $4,592,000 after purchasing an additional 7,111 shares in the last quarter. S.E.E.D. Planning Group LLC grew its stake in Agilent Technologies by 12.7% during the 4th quarter. S.E.E.D. Planning Group LLC now owns 42,587 shares of the medical research company’s stock worth $5,721,000 after purchasing an additional 4,805 shares in the last quarter. Miracle Mile Advisors LLC acquired a new position in Agilent Technologies during the 4th quarter worth $362,000. Finally, Massachusetts Financial Services Co. MA grew its stake in Agilent Technologies by 3.5% during the 3rd quarter. Massachusetts Financial Services Co. MA now owns 15,589,874 shares of the medical research company’s stock worth $2,314,784,000 after purchasing an additional 525,214 shares in the last quarter.

Analyst Upgrades and Downgrades

Several research analysts recently commented on the company. Citigroup boosted their target price on Agilent Technologies to $165.00 and gave the stock a “buy” rating in a research note on Thursday, December 19th. Robert W. Baird lowered their price objective on Agilent Technologies from $161.00 to $159.00 and set an “outperform” rating for the company in a research report on Thursday, February 27th. Sanford C. Bernstein lowered their price objective on Agilent Technologies from $140.00 to $135.00 and set a “market perform” rating for the company in a research report on Tuesday, November 26th. StockNews.com raised Agilent Technologies from a “hold” rating to a “buy” rating in a research report on Tuesday, December 24th. Finally, Bank of America lowered their price objective on Agilent Technologies from $153.00 to $150.00 and set a “neutral” rating for the company in a research report on Friday, December 13th. Seven analysts have rated the stock with a hold rating and eight have given a buy rating to the stock. Based on data from MarketBeat, Agilent Technologies currently has an average rating of “Moderate Buy” and a consensus target price of $146.15.

Insider Buying and Selling at Agilent Technologies

In other Agilent Technologies news, CEO Padraig Mcdonnell sold 1,911 shares of the company’s stock in a transaction that occurred on Tuesday, January 21st. The stock was sold at an average price of $150.00, for a total transaction of $286,650.00. Following the completion of the sale, the chief executive officer now directly owns 39,652 shares of the company’s stock, valued at $5,947,800. This represents a 4.60 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website.

Agilent Technologies Stock Down 0.6 %

Agilent Technologies stock opened at $121.15 on Wednesday. Agilent Technologies, Inc. has a fifty-two week low of $119.30 and a fifty-two week high of $155.35. The company has a debt-to-equity ratio of 0.56, a quick ratio of 1.66 and a current ratio of 2.20. The company has a market capitalization of $34.54 billion, a P/E ratio of 27.85, a PEG ratio of 3.42 and a beta of 1.11. The stock has a 50-day simple moving average of $139.16 and a 200-day simple moving average of $138.41.

Agilent Technologies (NYSE:A) last posted its quarterly earnings data on Wednesday, February 26th. The medical research company reported $1.31 EPS for the quarter, beating the consensus estimate of $1.27 by $0.04. The firm had revenue of $1.68 billion during the quarter, compared to the consensus estimate of $1.67 billion. Agilent Technologies had a return on equity of 25.56% and a net margin of 19.27%. Equities research analysts expect that Agilent Technologies, Inc. will post 5.57 earnings per share for the current year.

Agilent Technologies Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, April 23rd. Shareholders of record on Tuesday, April 1st will be paid a dividend of $0.248 per share. This represents a $0.99 annualized dividend and a yield of 0.82%. The ex-dividend date is Tuesday, April 1st. Agilent Technologies’s dividend payout ratio is presently 22.76%.

Agilent Technologies Company Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.